A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 412 participants.

Also called NCT01071850

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 412 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01071850
Other papers using this trial's data
  • Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus Journal of diabetes and its complications, 2013 DOI, PubMed 23276620

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Colombia, India, Mexico, Philippines (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01071850. Randomized; quadruple masking; primary purpose treatment. Start 2010-03-03 (actual); primary completion 2011-04-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
ipragliflozin
Intervention (Drug)
Metformin
Intervention (Drug)
Placebo
Lead sponsor
Astellas Pharma Inc (class: industry)

Record details

Record id
cardio:ct-nct01071850
Content hash
b8665df04c3cbd81a57a3629cb022bcdf54dbed47a3649ac4912d9077d8a90ae